Oncology and Hematology
Episodes 49-64 of 129
- CME/CE
PARP Inhibitors in Prostate Cancer: Improving Patient Outcomes Through Precision Therapy
1.00 creditTerran Sims, MSN, ACNP-C, CNN, COCN-C
Frank dela Rama, RN, MS, AOCNS, AGN-BC
Terran Sims, MSN, ACNP-C, CNN, COCN-C
Robert Lentz, MD
- CME/CE
Advancing Care and Improving Survival for Patients with HER2-Positive Breast Cancer
1.00 creditTerran Sims, MSN, ACNP-C, CNN, COCN-C
Jeremy Force
Donna Ryan, MD
Daniel Zalinov, PA-C
Megan Adelman, PharmD, BCPS, BCGP, CDCES
Caroline M. Apovian, MD, FTOS
Daniel Zalinov, PA-C
W. Scott Butsch, MD, MSc
Donna Ryan, MD
Caroline M. Apovian, MD, FTOS
Susan M. Tiso, DNP, APRN, FNP-BC, FAANP
Jonathan D. Schoenfeld, MD, MPhil, MPH
Robert L. Ferris, MD, PhD
Ezra Cohen, MD, FRCPSC, FASCO
Sue S. Yom, MD, PhD
Adam Brufsky, MD, PhD
Christopher M. Gallagher, MD
Christopher M. Gallagher, MD
- MinuteCE®
Importance of the Patient Perspective on RWE in Formulating SDM Conversations
0.75 program creditsAdam Brufsky, MD, PhD
Christopher M. Gallagher, MD
Christopher M. Gallagher, MD
Adam Brufsky, MD, PhD
Christopher M. Gallagher, MD
Adam Brufsky, MD, PhD
Adam Brufsky, MD, PhD
Christopher M. Gallagher, MD